Cat. No. 4737
Chemical Name: 1-(2-Cyano-3,12,28-trioxooleana-1,9
Biological ActivityNrf2 signaling activator; increases Nrf2 protein expression and enhances Nrf2-dependent cytoprotective gene expression. Inhibits cell growth and induces apoptosis of pancreatic cancer cells in vitro. Also reduces acetaminophen-induced liver injury in mice.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Aleksunes et al (2010) Transcriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity. J.Pharmacol.Exp.Ther. 335 2. PMID: 20605904.
Reisman et al (2009) CDDO-Im protects from acetaminophen hepatotoxicity through induction of Nrf2-dependent genes. Toxicol.Appl.Pharmacol. 236 109. PMID: 19371629.
Samudio et al (2005) 2-Cyano-3,12-dioxooleana-1,9-dien-28-imidazolide (CDDO-Im) directly targets mitochondrial glutathione to induce apoptosis in pancreatic cancer. J.Biol.Chem. 280 36273. PMID: 16118208.
If you know of a relevant reference for CDDO Im please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses CDDO Im from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: CDDO Im, supplier, CDDOIm, Nrf2, activators, NFE2L2, erythroid-derived, nuclear, factor, Tocris Bioscience, Nrf2 Activator products